Compounding pharmacy (US 503A)
Empower Pharmacy
Houston-based 503A and 503B compounding pharmacy. One of the largest US compounders of semaglutide, tirzepatide and peptide therapies.
United States · est. 2009
About
Houston-based 503A and 503B compounding pharmacy. One of the largest US compounders of semaglutide, tirzepatide and peptide therapies.
Peptides in this maker's catalogue
Brands
- Empower Semaglutide2.5 mg/mL, 4 mL vialCompounded (US 503A)503A→
- Empower Tirzepatide10 mg/mL, 2 mL vialCompounded (US 503A)503A→
- Empower Sermorelin15 mg lyophilised vialCompounded (US 503A)503A→
- Empower Tesamorelin10 mg lyophilised vialCompounded (US 503A)503A→
- Empower BPC-1575 mg lyophilised vialCompounded (US 503A)503A (FDA flagged 2023)→
- Empower Ipamorelin10 mg lyophilised vialCompounded (US 503A)503A (FDA flagged 2023)→
- Empower Oxytocin Nasal40 IU/mL nasal sprayCompounded (US 503A)503A→